Fertility Testing for Women Ages 35–39 in SoMa, San Francisco

Fertility Testing for Women Ages 35–39 in SOMA, San Francisco

For women ages 35–39 who are trying to conceive, fertility evaluation is commonly recommended after about six months without pregnancy, and sooner when there is a known concern such as irregular cycles, endometriosis, tubal disease, recurrent pregnancy loss or a sperm-related factor. The shorter timeline is not meant to create fear; it reflects the fact that age is clinically relevant when deciding how much time to spend gathering information or trying lower-intervention approaches.

Why Fertility Care Changes With Age—And Why 35 Is Not an Expiration Date

Female fertility changes gradually, not overnight at age 35. With increasing age, both the number of available eggs and the proportion expected to be chromosomally normal tend to decline. That is one reason assisted-reproduction outcomes are routinely reported by patient age: age meaningfully changes the context in which success rates and treatment choices should be interpreted.

At the same time, age alone cannot tell an individual what will happen. People of the same age can have different ovarian reserve, reproductive histories, diagnoses, sperm factors and family-building goals. Testing helps make the conversation personal rather than statistical.

What Fertility Testing Ages 35–39 May Include in SOMA, San Francisco

Evaluation may include AMH and ultrasound for ovarian reserve, assessment of ovulation and reproductive hormones, evaluation of the uterus and fallopian tubes, and semen analysis when applicable. Additional testing is guided by history rather than added automatically.

Ovarian Reserve, Egg Quality and Age: Three Different Ideas

Ovarian reserve tests help estimate egg quantity and likely response to ovarian stimulation. They do not directly measure egg quality. Age provides important information about the probability of chromosomal normalcy across a population, but it is not a test of an individual egg. Keeping those concepts separate helps prevent an AMH value—or a birthday—from being treated as a complete fertility prognosis.

Read more about how Spring physicians interpret diagnostic testing.

Fertility Testing for Women Ages 35–39 at Spring Fertility in SOMA, San Francisco

Spring’s SOMA clinic provides consultations and monitoring in downtown San Francisco. When treatment requires an egg retrieval, embryo transfer or other procedure, care moves to Spring’s Pacific Heights center. The two San Francisco clinics operate as one program: your physician and treatment plan carry across locations rather than restarting when a procedure is needed.

This model allows patients to complete appointment-heavy monitoring downtown in SOMA while accessing Spring’s embryology lab and surgery center at Pacific Heights for procedures. The aim is to understand whether there is a reason to act now, what treatment intensity is justified and how your desired family size should influence today’s decision.

How Testing Can Influence Treatment Decisions in SOMA, San Francisco

Some patients may reasonably continue trying or use lower-intervention treatment; others may decide that IVF offers an important efficiency advantage. Spring physicians consider age together with ovarian reserve, diagnosis, sperm factors, prior treatment, timeline and goals rather than assuming that everyone in the 35–39 age range needs the same treatment. See how Spring specialists choose among treatment options.